| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Coherus Biosciences Inc(CHRS) | 305,505 | $8.6M | 46.45% |
| 2 | BioCryst Pharmaceuticals Inc(BCRX) | 1,155,104 | $7.3M | 39.49% |
| 3 | Ascendis Pharma A/S(ASND) | 90,000 | $1.8M | 9.84% |
| 4 | CytomX Therapeutics Inc(CTMX) | 64,200 | $706.0K | 3.81% |
| 5 | DBV Technologies | 456,893 | $31.1K | 0.17% |
| 6 | Heron Therapeutics Inc(HRTX) | 1,095,734 | $14.4K | 0.08% |
| 7 | Avadel Pharmaceuticals | 500,000 | $5.2K | 0.03% |
| 8 | Ra Pharmaceuticals | 232,500 | $3.5K | 0.02% |
| 9 | Adverum Biotechnologies(ADVMCHF) | 1,102,735 | $3.2K | 0.02% |
| 10 | Lipocine Inc | 849,921 | $3.1K | 0.02% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 99.62% | 99.67% | +0.05% |
| Unclassified | 0.38% | 0.33% | -0.05% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Micro Cap | 47.99% | 46.53% | -1.46% |
| Mid Cap | 25.95% | 39.49% | +13.54% |
| Large Cap | 19.78% | 9.84% | -9.94% |
| Small Cap | 5.9% | 3.81% | -2.09% |
| Unclassified | 0.38% | 0.33% | -0.05% |
Quarter-over-quarter position changes